Senstar Technologies Ltd. - Ordinary Shares SNT 深 滬
等待開盤 10-15 09:30:00 美东时间
4.545
-0.055
-1.20%
華盛通- 最 高4.7599
- 今 開4.55
- 成交量 5.15万股
- 最 低 4.52
- 昨 收 4.60
- 總市值 1.06亿
- 52周最高 5.0499
- 市盈率 靜 27.66
- 換手率 0.22%
- 52周最低 1.40
- 委 比 77.51%
- 總股本 2333.17万
- 歷史最高 5.196
- 量 比 1.14
- 振 幅 5.22%
- 歷史最低 -0.624
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
New independent director Mark W. Hahn joins Soleno Therapeutics' Board, bringing 30 years of financial leadership experience. Hahn's expertise will support the company's commercial launch of VYKAT™ XR for treating hyperphagia in Prader-Willi syndrome. His background includes successful product launches and financings in the life sciences sector. With his addition, the Board now has seven members. Hahn also serves as Audit Committee Chair for Opte...
10-13 12:00
Syntara Strengthens Leadership for Amsulostat Development
Pharmaxis Ltd ( ($AU:SNT) ) just unveiled an update. Syntara Limited has announ...
09-30 07:28
Syntara Limited Secures A$5.6 Million R&D Tax Incentive
An announcement from Pharmaxis Ltd ( ($AU:SNT) ) is now available. Syntara Limi...
09-24 11:48
Pharmaxis Ltd Highlights Strategic Initiatives at Healthcare Conference
An update from Pharmaxis Ltd ( ($AU:SNT) ) is now available. Pharmaxis Ltd rece...
09-09 07:10
Pharmaxis Receives FDA Guidance on Amsulostat’s Clinical Pathway
The latest update is out from Pharmaxis Ltd ( ($AU:SNT) ). Pharmaxis Ltd has re...
09-01 07:57
Syntara Limited Enhances Corporate Governance Framework
The latest update is out from Pharmaxis Ltd ( ($AU:SNT) ). Syntara Limited has ...
08-28 16:57
Syntara Limited Affirms Governance Compliance for FY2025
Pharmaxis Ltd ( ($AU:SNT) ) has provided an update. Syntara Limited has release...
08-28 16:48
12 Information Technology Stocks Moving In Tuesday's Pre-Market Session
Gainers Aehr Test System (NASDAQ:AEHR) shares increased by 8.9% to $26.77 duri...
08-26 20:09
电话会总结 ｜ Senstar(SNT)2025财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Senstar (SNT)的业绩会实录,我总结如下:</p> <p>• 财务业绩: - 2025财年第二季度总收入为9.7百万美元,同比增长16.2% - 毛利率为66.1% - 营业利润为1百万美元 - EBITDA为1.1百万美元 - 净利润为1.2百万美元,每股收益0.05美元 - 截至2025年6月30日,现金及短期存款为21.9百万美元,无债务</p> <p>• 财务指标变化: - 总收入同比增长16.2% - 毛利率同比提高292个基点,从63.2%增至66.1% - 营业利润同比增长46% - 营业利润率同比
08-26 12:03
Senstar Tech Q2 EPS $0.05 Up From $0.02 YoY, Sales $9.65M Up From $8.31M YoY
Senstar Tech (NASDAQ:SNT) reported quarterly earnings of $0.05 per share. This is a 150 percent increase over earnings of $0.02 per share from the same period last year. The company reported $9.65 million in sales this
08-26 04:14
